NEW YORK, NY / ACCESS Newswire / June 11, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
You might also be interested in reading Web3 Builders Lose Dozens of High-Value NFTs in Back-to-Back Attacks.
